2022 American Transplant Congress
Assessment of Letermovir as Universal Prophylaxis for Cytomegalovirus Infection in Lung Transplant Recipients
*Purpose: Cytomegalovirus (CMV) poses a significant concern in the post-operative management of lung transplant (LT) recipients. Current recommended prophylactic strategies with ganciclovir (GCV) or valganciclovir…2022 American Transplant Congress
Effects of Pre-Lung Transplantation Pulmonary Rehabilitation on Functional Capacity and Quality of Life
*Purpose: Pulmonary rehabilitation (PR) prior lung transplantation (LT) has been effective in reducing post transplantation complications. However, few studies have examined the effect of pre-lung…2022 American Transplant Congress
Data-Driven Clustering Distinguishes Infection from Rejection During Hospital Admissions Following Pediatric Lung Transplantation
*Purpose: When lung transplantation patients are admitted with respiratory symptoms, distinguishing between episodes of infection and rejection is central to determining immunosuppressive management.*Methods: Data comprising…2022 American Transplant Congress
Single Center Retrospective Study Examining the Incidence of Chronic Kidney Disease After Lung Transplantation and Its Associated Risk Factors
*Purpose: To examine the incidence of chronic kidney disease (CKD) after lung transplantation and to evaluate the recipient-related risk factors associated with the development of…2022 American Transplant Congress
Pooled Prevalence of Pulmonary Embolism in Lung Transplant Recipients – A Meta-Analysis
Department of Pulmonary and Critical Care, Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Similar to other operations, lung transplantation surgery has been associated with an increased risk of venous thromboembolism. While various studies have aimed to estimate…2022 American Transplant Congress
Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?
University of Alabama Birmingham, Birmingham, AL
*Purpose: A Systems Improvement Agreement (SIA) is a voluntary and binding legal agreement between CMS and a Medicare certified hospital designed to address Condition level…2022 American Transplant Congress
Utility of Bronchoalveolar Lavage Cytology for Detection of Malignancy or Infection in Lung Transplant Recipients
*Purpose: The role of cytologic evaluation in the diagnosis of acute allograft dysfunction has been described. Specific changes in cell count of bronchoalveolar lavage during…2021 American Transplant Congress
Evaluation of Fungal Prophylaxis Post-Lung Transplantation
1Temple University Hospital, Philadelphia, PA, 2Temple School of Pharmacy, Philadelphia, PA
*Purpose: Fungal infections are responsible for approximately 15-35% of all infections in lung transplant recipients; 80% of which are due to aspergillus or candida. At…2021 American Transplant Congress
Tacrolimus Dose Requirements in Lung Transplant Recipients on Systemic Azole Antifungals: The Influence of Race and Transplant Indication
*Purpose: CYP3A5 polymorphisms, drug interactions, and alterations in gastric absorption impact tacrolimus metabolism. This is important for those at higher risk of expressing these factors,…2021 American Transplant Congress
A Patient-Centered Perspective on Progress in Transplantation
*Purpose: This study aimed to provide a patient-centered perspective on change in transplantation outcomes through analysis of intent-to-treat survival, which accounted for donor shortages by…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 10
- Next Page »